At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Novel Smartphone-based Intervention to Support Smoking Cessation and Adherence to Antiretroviral Therapy Among People Living With HIV: A Pilot Randomized Clinical Trial
In Brief
A Phase 4 clinical trial evaluating Nicoderm C-Q Transdermal Product, Adherence to Antiretroviral Therapy Counseling, and 3 other interventions for Smoking and 2 related conditions. Completed, enrolled 39 participants across 1 site.
Detailed Summary
The purpose of this study is to learn if a mindfulness-based smoking cessation smartphone app can help people quit smoking and stay on antiretroviral therapies.
Study Details
Timeline
Interventions
6 weeks of GlaxoSmithKline Nicoderm CQ (NRT)
Brief counseling on adhering to antiretroviral therapy with self-help materials.
One time face-to-face smoking cessation counseling and 2 follow-up phone calls.
Evidence-based mindfulness smoking cessation smartphone app ("Crave-to-Quit") adapted from an in-person mindfulness training relapse prevention smoking cessation intervention.
Video Directly Observed Therapy (vDOT) smartphone app ("emocha") that allows participants to take a video of themselves taking medication to ensure adherence.